PNC Financial Services Group
SCMP

PNC Financial Services Group’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

PNC Financial Services Group’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-5,611
Closed -$101K – 4390
2017
Q4 		$101K Buy
5,611
+171
+3% +$2.1K ﹤0.01% 2561
2017
Q3 		$64K Buy
5,440
+457
+9% +$5.13K ﹤0.01% 2797
2017
Q2 		$52K Buy
4,983
+743
+18% +$7.57K ﹤0.01% 2881
2017
Q1 		$47K Buy
4,240
+62
+1% +$720 ﹤0.01% 2921
2016
Q4 		$57K Buy
4,178
+3,678
+736% +$51.3K ﹤0.01% 2772
2016
Q3 		$6K Sell
500
-189
-27% -$2.23K ﹤0.01% 3662
2016
Q2 		$7K Sell
689
-7
-1% -$78 ﹤0.01% 3721
2016
Q1 		$7K Sell
696
-1,284
-65% -$16.2K ﹤0.01% 3733
2015
Q4 		$35K Buy
1,980
+1,826
+1,186% +$32.7K ﹤0.01% 3012
2015
Q3 		$3K Buy
154
+5
+3% +$115 ﹤0.01% 4207
2015
Q2 		$2K Buy
149
+68
+84% +$1.18K ﹤0.01% 4479
2015
Q1 		$1K Buy
81
+58
+252% +$899 ﹤0.01% 4590
2014
Q4 		$0 Buy
+23
New +$243 ﹤0.01% 4323

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

PNC Financial Services Group's SCMP Position: Q1 2018 in Review

PNC Financial Services Group sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 5,611 shares — an estimated $101K sold.

PNC Financial Services Group first reported a position in SCMP in Q4 2014 and held it in 13 quarters. The position peaked at $101K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • PNC Financial Services Group reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • PNC Financial Services Group sold 5,611 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $101K.
  • PNC Financial Services Group first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2014 and held it in 13 quarters.
  • PNC Financial Services Group's Sucampo Pharmaceuticals, Inc. position peaked at $101K in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on PNC Financial Services Group's 13F filing for Q1 2018, filed 11 May 2018.